BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6102950)

  • 1. Calcitonin-producing pancreatic somatostatinoma.
    Galmiche JP; Chayvialle JA; Dubois PM; David L; Descos F; Paulin C; Ducastelle T; Colin R; Geffroy Y
    Gastroenterology; 1980 Jun; 78(6):1577-83. PubMed ID: 6102950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
    Patel YC; Ganda OP; Benoit R
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatinoma syndrome. Biochemical, morphologic and clinical features.
    Krejs GJ; Orci L; Conlon JM; Ravazzola M; Davis GR; Raskin P; Collins SM; McCarthy DM; Baetens D; Rubenstein A; Aldor TA; Unger RH
    N Engl J Med; 1979 Aug; 301(6):285-92. PubMed ID: 377080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic islet cell carcinoma producing gastrin, ACTH, alpha-endorphin, somatostatin and calcitonin.
    Asa SL; Kovacs K; Killinger DW; Marcon N; Platts M
    Am J Gastroenterol; 1980 Jul; 74(1):30-5. PubMed ID: 6107042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant islet cell tumor of the pancreas associated with high plasma calcitonin and somatostatin levels.
    Howard JM; Gohara AF; Cardwell RJ
    Surgery; 1989 Feb; 105(2 Pt 1):227-9. PubMed ID: 2563598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin-producing pancreatic somatostatinoma: report of a case.
    Sugimoto F; Sekiya T; Saito M; Iiai T; Suda K; Nozawa A; Nakazawa T; Ishizaki T; Ikarashi T
    Surg Today; 1998; 28(12):1279-82. PubMed ID: 9872549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
    Birnbaum RS; Muszynski M; Roos BA
    Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.
    Iguchi H; Kumagai S; Seo IH; Wakasugi H; Hara Y; Abe M
    J Clin Endocrinol Metab; 1988 Jul; 67(1):206-10. PubMed ID: 2897973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of somatostatinoma: responses to food and SMS 201-995 administration.
    Davis TM; Bray G; Domin J; Bloom SR
    Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.
    Kohnert KD; Kändler C; Woltanski KP; Ziegler M
    Exp Clin Endocrinol; 1985 Feb; 85(1):89-94. PubMed ID: 2985414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Somatostatinoma": follow-up studies.
    Ganda OP; Soeldner JS
    N Engl J Med; 1977 Dec; 297(24):1352-3. PubMed ID: 199841
    [No Abstract]   [Full Text] [Related]  

  • 12. A new bioactive form of human calcitonin.
    Tobler PH; Dambacher MA; Born W; Heitz PU; Maier R; Fischer JA
    Cancer Res; 1983 Aug; 43(8):3793-9. PubMed ID: 6861143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin secretion by a pancreatic somatostatinoma.
    Galmiche JP; Colin R; DuBois PM; Chayvialle JA; Descos F; Paulin C; Geffroy Y
    N Engl J Med; 1978 Nov; 299(22):1252. PubMed ID: 714084
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatostatinoma syndrome is clinically diagnosed.
    Am Fam Physician; 1979 Dec; 20(6):140, 145. PubMed ID: 229723
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
    Pipeleers D; Somers G; Gepts W; De Nutte N; De Vroede M
    J Clin Endocrinol Metab; 1979 Oct; 49(4):572-9. PubMed ID: 158032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal somatostatinoma with psammoma bodies: an immunohistochemical and ultrastructural study.
    Taccagni GL; Carlucci M; Sironi M; Cantaboni A; Di Carlo V
    Am J Gastroenterol; 1986 Jan; 81(1):33-7. PubMed ID: 2867674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of duodenal somatostatinoma: diagnostic usefulness of calcium--pentagastrin test.
    Somers G; Pipeleers-Marichal M; Gepts W; Pipeleers D
    Gastroenterology; 1983 Nov; 85(5):1192-8. PubMed ID: 6137434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
    Rude RK; Matsumoto S; Singer FR
    Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
    Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.